MAKOplasty®

FORT LAUDERDALE, Fla., May 7, 2013 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced its operating results for the quarter ended March 31, 2013.

FT. LAUDERDALE, Fla., April 25, 2013 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to release first quarter 2013 financial results after market close on Tuesday, May 7, 2013. Maurice R. Ferré, M.D., President and Chief Executive Officer, and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will host a conference call to review the first quarter 2013 results starting at 4:30 pm ET on the same day. The call will be concurrently webcast.

FORT LAUDERDALE, Fla., April 16, 2013 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) and Stanmore Implants Worldwide Ltd. today announced that MAKO has agreed to settle all patent infringement actions and acquire certain assets of Stanmore related to its Sculptor Robotic Guidance Arm (RGA) business.

FORT LAUDERDALE, Fla., April 4, 2013 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) today announced that it has obtained an Order Granting Permanent Injunction enjoining Blue Belt Technologies, Inc. from engaging a former MAKO employee and requiring the destruction of all proprietary MAKO business information in Blue Belt's possession.

CHICAGO, March 21, 2013 (GLOBE NEWSWIRE) -- MAKO Surgical Corp., developer of human-interactive surgical robotic arm technology used to achieve accuracy in treating osteoarthritic disease, today announced the first results from a ten-year, prospective, randomized controlled trial evaluating the accuracy of unicompartmental knee arthroplasty (UKA) implant positioning, with and without robotic arm surgical assistance. Early results from this pivotal study are compelling, showing that robotic arm assisted UKA enhanced the accuracy of implant placement and decreased the levels of pain.

FORT LAUDERDALE, Fla., March 19, 2013 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) today announced that it has filed complaints against Stanmore Implants Worldwide, Ltd. of Elstree, United Kingdom and Stanmore Inc. of Plymouth, Massachusetts with the U.S. International Trade Commission, and the U.S. District Courts of the Northern District of California and the District of Massachusetts collectively alleging infringement of three patents by Stanmore. The patents at issue relate to computerized orthopedic surgical devices and software, and the patent infringement actions are directed at Stanmore's computerized orthopedic surgery guidance systems, including Stanmore's Sculptor Robotic Guidance Arm.

CHICAGO, March 18, 2013 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), the leader in robotic arm assisted partial knee and total hip arthroplasty worldwide, today announced that it will showcase its MAKOplasty® Total Hip Arthroplasty (THA) and Partial Knee Resurfacing applications at the American Academy of Orthopaedic Surgeons 2013 Annual Meeting (AAOS), March 20-23 at McCormick Place in Chicago. During the meeting, orthopedic surgeons will deliver presentations and provide hands-on demonstrations in MAKO's booth #212.

FORT LAUDERDALE, Fla., Feb. 26, 2013 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced its operating results for the quarter and year ended December 31, 2012.

FORT LAUDERDALE, Fla., Feb. 21, 2013 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications, and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, is pleased to announce the advancement of Christopher R. Marrus to Senior Vice President of Sales.

FORT LAUDERDALE, Fla., Jan. 7, 2013 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications, and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced its selected operating results for the fourth quarter and the year ended December 31, 2012 in anticipation of its business update presentation at the 31st Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Wednesday, January 9, 2013 at 7:30 am PT.

FT. LAUDERDALE, Fla., Dec. 19, 2012 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferré, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the 31st Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Wednesday, January 9, 2013 at 7:30 am PT. A webcast will be available and may be accessed by visiting MAKO's website at www.makosurgical.com under the Investor Relations section. A replay of the webcast will be available immediately after the conclusion of the presentation.

FT. LAUDERDALE, Fla., Nov. 16, 2012 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferré, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the 24th Annual Piper Jaffray Health Care Conference at The New York Palace in New York on Tuesday, November 27, 2012 at 8:00 am ET.

FORT LAUDERDALE, Fla., Nov. 14, 2012 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced the pricing of its previously announced underwritten public offering. Pursuant to the offering, MAKO has sold 3,042,000 shares of its common stock at a public offering price of $13.15 per share. In connection with the offering, MAKO has also granted the underwriter a 30-day option to purchase up to an additional 456,300 shares of common stock to cover over-allotments, if any. Piper Jaffray & Co. acted as the sole manager for the offering. Moelis & Company acted as financial advisor to MAKO.

FORT LAUDERDALE, Fla., Nov. 13, 2012 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced that it intends to offer shares of its common stock in a public offering. Piper Jaffray & Co. is acting as the sole manager for the offering.

FORT LAUDERDALE, Fla., Nov. 7, 2012 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced its operating results for the quarter ended September 30, 2012.

FT. LAUDERDALE, Fla., Oct. 18, 2012 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to release third quarter 2012 financial results after market close on Wednesday, November 7, 2012. Maurice R. Ferré, M.D., President and Chief Executive Officer, and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will host a conference call to review the third quarter 2012 results starting at 4:30 pm ET on the same day. The call will be concurrently webcast.

FORT LAUDERDALE, Fla., Aug. 1, 2012 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications, and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced its operating results for the quarter ended June 30, 2012.

FT. LAUDERDALE, Fla., July 23, 2012 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to release second quarter 2012 financial results after market close on Wednesday, August 1, 2012. Maurice R. Ferré, M.D., President and Chief Executive Officer, and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will host a conference call to review the second quarter 2012 results starting at 4:30 pm ET on the same day. The call will be concurrently webcast.

FORT LAUDERDALE, Fla., July 18, 2012 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications, and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced that Steven J. Nunes tendered his resignation as MAKO's Senior Vice President of Sales & Marketing effective July 17, 2012. Maurice R. Ferré, M.D., MAKO's President and Chief Executive Officer, will assume sales responsibilities on an interim basis while MAKO conducts a search for a Senior Vice President of Sales. Ivan Delevic, MAKO's Senior Vice President of Strategic Marketing and Business Development, will transition to the new role of Senior Vice President of Marketing and assume commercial marketing responsibilities, in addition to his existing strategic marketing responsibilities.

FORT LAUDERDALE, Fla., July 9, 2012 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications, and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced its selected operating results for the quarter ended June 30, 2012.

FT. LAUDERDALE, Fla., May 30, 2012 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferré, M.D., President and Chief Executive Officer of MAKO, will present at the Goldman Sachs 33rd Annual Global Healthcare Conference at the Terranea Resort at Ranchos Palos Verdes, CA on Tuesday, June 5, 2012 at 11:20 am PT. The presentation was originally scheduled for Thursday, June 7, 2012 at 8:40 am PT.

FT. LAUDERDALE, FL – (GLOBENEWSWIRE) — May 25, 2012—MAKO Surgical Corp. (Nasdaq: MAKO) announced today that Maurice R. Ferré, M.D., President and Chief Executive Officer, and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the Goldman Sachs 33rd Annual Global Healthcare Conference at the Terranea Resort at Ranchos Palos Verdes, CA on Thursday, June 7, 2012 at 8:40 am PT.

FORT LAUDERDALE, FL, May 7, 2012 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications, and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced its operating results for the quarter ended March 31, 2012.

FORT LAUDERDALE, FL – (GLOBENEWSWIRE) — March 6, 2012 —MAKO Surgical Corp. (NASDAQ:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications, and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced its operating results for the quarter and year ended December 31, 2011.

FT. LAUDERDALE, FL – (GLOBENEWSWIRE) — February 28, 2012—MAKO Surgical Corp. (NASDAQ: MAKO) announced today that Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the Barclays Capital 2012 Global Healthcare Conference at the Loews Miami Beach Hotel in Miami on Wednesday, March 14, 2012 at 2:00 pm ET.

FT. LAUDERDALE, FL – (GLOBENEWSWIRE) — February 14, 2012—MAKO Surgical Corp. (NASDAQ: MAKO) announced today that Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the Leerink Swann 2012 Global Healthcare Conference at the Waldorf Astoria in New York on Thursday, February 16 at 2:30 pm ET.

SAN FRANCISCO, Feb. 8, 2012 /PRNewswire/ -- MAKO Surgical Corp. (NASDAQ: MAKO), a leader in robotic arm assisted partial knee arthroplasty worldwide, today announced the MAKOplasty® Total Hip Arthroplasty (THA) application will be featured at the American Academy of Orthopaedic Surgeons 2012 Annual Meeting (AAOS) being held on February 7-11, 2012 at the Moscone Center in San Francisco, California.

FT. LAUDERDALE, FL – (GLOBENEWSWIRE) — February 6, 2012—MAKO Surgical Corp. (Nasdaq: MAKO) announced today that the Company will host an event for research analysts and investors where surgeons will discuss their experience with MAKOplasty. This event will be held concurrent with the American Academy of Orthopaedic Surgeons 2012 Annual Meeting in San Francisco on Wednesday, February 8 at 6:00 pm Pacific Time. AKO Surgical Corp. (NASDAQ:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications, and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced its selected operating results for its fourth quarter and for the year ended December 31, 2011 and provided 2012 annual guidance in anticipation of its business update presentation at the 30th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Wednesday, January 11, 2012 at 7:30 am PST.

FT. LAUDERDALE, FL – (GLOBENEWSWIRE) — January 25, 2012—MAKO Surgical Corp. (Nasdaq: MAKO) announced today that Maurice R. Ferré, M.D., President and Chief Executive Officer, and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the Canaccord Genuity Musculoskeletal Conference at the Parc 55 in San Francisco on Tuesday, February 7 at 9:20 am PT.

FORT LAUDERDALE, FL – (GLOBENEWSWIRE) — January 9, 2012 —MAKO Surgical Corp. (NASDAQ:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications, and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced its selected operating results for its fourth quarter and for the year ended December 31, 2011 and provided 2012 annual guidance in anticipation of its business update presentation at the 30th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Wednesday, January 11, 2012 at 7:30 am PST.

Ft. Lauderdale, Fla. – Gov. Rick Scott today joined MAKO Surgical Corp. to celebrate the medical device company’s expansion which is projected to bring nearly 100 new jobs to South Florida. The company will build its RIO® Robotic Arm Interactive Orthopedic system at a new Fort Lauderdale facility, evidence that South Florida’s high-tech sector is on the rise.

FORT LAUDERDALE, FL – (GLOBENEWSWIRE) — November 9, 2011 —MAKO Surgical Corp. (NASDAQ:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications, and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced its operating results for the quarter ended September 30, 2011.

FT. LAUDERDALE, FL – (GLOBENEWSWIRE) — October 28, 2011—MAKO Surgical Corp. (Nasdaq: MAKO) announced today that it plans to release third quarter 2011 financial results after market close on Wednesday, November 9, 2011. Maurice R. Ferré, M.D., President and Chief Executive Officer, and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will host a conference call to review the third quarter 2011 results starting at 4:30 pm ET on the same day. The call will be concurrently webcast...

MAKO Surgical Corp. (NASDAQ:MAKO) today announced it ranked No. 1 on Deloitte’s Technology Fast 500™, ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America…

Robotic Arm-Assisted Technology Provides Surgeons With Consistently Reproducible Precision in Hip Replacement Surgery MAKOplasty Total Hip Arthroplasty is Designed to Help Surgeons Restore Patient Mobility and Lifestyle FT. LAUDERDALE, Fla., Sept. 19, 2011 (GLOBE NEWSWIRE) — MAKO Surgical Corp. (Nasdaq:MAKO) today announc…

FT. LAUDERDALE, FL – (GLOBENEWSWIRE) — May 16, 2011 — MAKO Surgical Corp. (NASDAQ:MAKO) announces the development of the MAKOplasty.com website with social media links to Facebook, Twitter and YouTube that provides consumers seeking innovative treatment for early to mid-osteoarthritis, with a variety of online channels of communications for global engagement.

FT. LAUDERDALE, FL – (GLOBENEWSWIRE) — May 3, 2011 — MAKO Surgical Corp. (NASDAQ:MAKO), a medical device company that markets both its RIO^® Robotic Arm Interactive Orthopedic surgical platform and proprietary RESTORIS^® implants for minimally invasive orthopedic knee procedures known as knee MAKOplasty^®, today announced its operating results for the quarter ended March 31, 2011…..

FT. LAUDERDALE, FL – (GLOBENEWSWIRE) — April 28, 2011—MAKO Surgical Corp. (Nasdaq: MAKO) announced today that Maurice R. Ferré, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present….

FT. LAUDERDALE, FL – (GLOBENEWSWIRE) — April 19, 2011—MAKO Surgical Corp. (Nasdaq: MAKO) announced today that it plans to release first quarter 2011 financial results after market close on Tuesday, May 3, 2011. Maurice R. Ferré, M.D., President and Chief Executive Officer, and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will host a conference….

FORT LAUDERDALE, Fla., March 30, 2011 (GLOBE NEWSWIRE) In a release issued earlier today by MAKO Surgical Corp.(Nasdaq:MAKO), the company Health Management Associates, Inc. (NYSE:HMA) was incorrectly referred to as “HospitalManagement Associates” in the headline and first paragraph….

FORT LAUDERDALE, FL – (GLOBENEWSWIRE) — March 1, 2011 —MAKO Surgical Corp. (NASDAQ:MAKO), a medical device company that markets both its RIO^® Robotic Arm Interactive Orthopedic surgical platform and proprietary RESTORIS^® implants for minimally invasive orthopedic knee procedures known as knee MAKOplasty^®, today announced its operating results for the fourth quarter…

Fourth Quarter 2010 and Full Year Highlights Thirteen RIO^® Systems Sold in the Quarter, Increasing Domestic Commercial Installed Base to 67 RIO Systems Total of 33 RIO Systems Sold Worldwide in 2010 1,146 MAKOplasty^® Procedures Performed in the Quarter, a 104% Increase Over the Same Period in 2009 Total of 3,485 MAKO…

FORT LAUDERDALE, Fla., Nov. 4, 2010 (GLOBE NEWSWIRE) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets both its RIO^® Robotic Arm Interactive Orthopedic surgical platform and proprietary RESTORIS^® implants for minimally invasive orthopedic procedures known as knee MAKOplasty^®, today announced the pricing of the public offer…

FORT LAUDERDALE, Fla., Nov. 3, 2010 (GLOBE NEWSWIRE) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets both its RIO^® Robotic Arm Interactive Orthopedic surgical platform and proprietary RESTORIS^® implants for minimally invasive orthopedic procedures known as knee MAKOplasty^®, today announced that it intends, subject to mar…

Nov 2, 2010 (GlobeNewswire via COMTEX News Network) — Third Quarter 2010 Highlights Third quarter revenue totaled $12.0 million, a 79% increase over revenue generated in the same period in 2009 Nine RIO(R) systems sold, increasing domestic commercial installed base to 54 RIO systems Through the third quarter of 2010, a total of 20 RIO…

FT. LAUDERDALE, Fla., Aug 31, 2010 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the Morgan Stanley Global Healthcare Conference at the Gra…

Aug 3, 2010 (GlobeNewswire via COMTEX News Network) — Second Quarter 2010 Highlights Second quarter revenue totaled $10.3 million, a 151% increase over total revenue generated in the same period in 2009 Seven RIO^® systems sold, increasing domestic commercial installed base to 46 RIO systems 793 MAKOplasty^® procedures performed, a 1…

FT. LAUDERDALE, Fla., Jul 19, 2010 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to release second quarter 2010 financial results after market close on Tuesday, August 3, 2010. Maurice R. Ferre, M.D., President and Chief Executive Officer, and Fritz L. LaPorte, Senior Vice President and C…

FT. LAUDERDALE, Fla., Jun 10, 2010 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) announced that its RIO^® Robotic Arm Interactive Orthopedic System has received a 2010 Gold Medical Design Excellence Award. RIO^® is used to perform MAKOplasty^® partial knee resurfacing, a treatment option for patients with early to…

FT. LAUDERDALE, Fla., Jun 8, 2010 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the 2010 Wells Fargo Securities Healthcare Conference at Th…

A state-of-the-art robotic arm for orthopaedic surgery that has the potential to transform the way in which knee joint replacements are conducted in the UK and reduce cost, is to be employed in clinical studies at the NHS Greater Glasgow and Clyde’s Royal Infirmary and the University of Strathclyde. It is the first time the robotic arm t…

A state-of-the-art robotic arm for orthopaedic surgery that has the potential to transform the way in which knee joint replacements are conducted in the UK and reduce cost, is to be employed in clinical studies at the NHS Greater Glasgow and Clyde’s Royal Infirmary and the University of Strathclyde. It is the first time the robotic arm t…

Mar 8, 2010 (GlobeNewswire via COMTEX News Network) — Highlights Fourth quarter revenue totaled $8.9 million Commercial installed base increased by seven systems to 36 RIO^® systems 561 MAKOplasty^® procedures performed, a 34% sequential increase from third quarter 2009 FORT LAUDERDALE, Fla., March 8, 2010 (GLOBE NEWSWIRE) — MAK…

Jan 7, 2010 (GlobeNewswire via COMTEX News Network) — Highlights Commercial installed base increased by seven systems to 36 RIO^® systems 561 MAKOplasty^® procedures performed, a 34% increase from third quarter 2009 FORT LAUDERDALE, Fla., Jan. 7, 2010 (GLOBE NEWSWIRE) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company tha…

FT. LAUDERDALE, Fla., Dec 2, 2009 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company focused on marketing its advanced robotic-arm solution and its implants for minimally invasive orthopedic knee procedures known as MAKOplasty^®, today announced the commercial availability of the Lateral Unicompa…

FT. LAUDERDALE, Fla., Dec 2, 2009 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company focused on marketing its advanced robotic-arm solution and its implants for minimally invasive orthopedic knee procedures known as MAKOplasty^®, today announced the commercial availability of the Lateral Unicompa…

MAKO Surgical Corp. [MAKO], an orthopedic medical device company that completed its initial public offering and began publicly trading on NASDAQ in February of 2008, will visit the NASDAQ MarketSite in New York City’s Times Square…

FORT LAUDERDALE, Fla., Aug 14, 2009 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets both its RIO^® Robotic Arm Interactive Orthopedic surgical platform and proprietary RESTORIS^® implants for minimally invasive orthopedic knee procedures known as MAKOplasty^®, today announced th…

FORT LAUDERDALE, Fla., Aug 13, 2009 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets both its RIO^® robotic arm interactive orthopedic surgical platform and proprietary RESTORIS^® implants for minimally invasive orthopedic knee procedures known as MAKOplasty^®, today announced th…

Aug 4, 2009 (GlobeNewswire via COMTEX News Network) — Highlights Second quarter revenue totaled $14.9 million All RIO^® system upgrades completed, associated deferred revenue recognized Commercial installed base increased to 23 RIO systems RIO system enables RESTORIS^® MCK uni and bicompartmental knee procedures MA…

FORT LAUDERDALE, Fla., May 18, 2009 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets both its robotic arm interactive orthopedic surgical platform and proprietary RESTORIS^® implants for minimally invasive orthopedic knee procedures known as MAKOplasty^®, today announced that it h…

FORT LAUDERDALE, Fla., May 6, 2009 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets both its robotic arm interactive orthopedic surgical platform and proprietary RESTORIS^® implants for minimally invasive orthopedic knee procedures known as MAKOplasty^®, today announced its operat…

FT. LAUDERDALE, Fla., Feb 24, 2009 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) will unveil the next generation of its robotic arm system and implants used for MAKOplasty^® partial knee resurfacing, at the American Academy of Orthopaedic Surgeons (AAOS) 2009 Annual Meeting, February 25- 28 in Las Vegas. A photo…

FT. LAUDERDALE, Fla., Feb 12, 2009 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the Canaccord Adams Musculoskeletal Conference at the Univ…

FORT LAUDERDALE, Fla., Jan 27, 2009 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company focused on marketing its MAKO RIO^™ System, a robotic arm interactive orthopedic surgical platform, and its RESTORIS^® implants for minimally invasive orthopedic knee procedures known as MAKOplasty^®, announ…

FORT LAUDERDALE, Fla., Jan 12, 2009 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company focused on marketing its Tactile Guidance System^™ (TGS^™), an advanced robotic-arm solution, and its implants for a minimally invasive orthopedic knee procedure, known as MAKOplasty^®, today announced sele…

FT. LAUDERDALE, Fla., Dec 30, 2008 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the 27th Annual J.P. Morgan Healthcare Conference at the W…

FT. LAUDERDALE, Fla., Dec 2, 2008 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company focused on marketing its advanced robotic-arm solution and its implants for minimally invasive orthopedic knee procedures known as MAKOplasty^®, today announced that it received two 510(k) clearances from the US…

FT. LAUDERDALE, Fla., Nov 20, 2008 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the Piper Jaffray 20th Annual Health Care Conference at Th…

FORT LAUDERDALE, Fla., Nov 11, 2008 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the Lazard Capital Markets 5th Annual Healthcare Conferen…

FORT LAUDERDALE, Fla., Nov 6, 2008 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company focused on marketing its Tactile Guidance System^™ (TGS^™), an advanced robotic-arm solution, and its implants for a minimally invasive orthopedic knee procedure, known as MAKOplasty^®, today announced its f…

FORT LAUDERDALE, Fla., Nov 4, 2008 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Thomas M. Coon, M.D. of St. Elizabeth Community Hospital will present a live surgical webcast of a MAKOplasty^® partial knee resurfacing procedure, which utilizes robotic arm technology, on December 1st at 3:00 p.m….

FT. LAUDERDALE, Fla., Oct 29, 2008 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company focused on marketing its Tactile Guidance System^™ (TGS^™), an advanced robotic-arm solution, and its implants for minimally invasive orthopedic knee procedures, known as MAKOplasty^®, today announced that i…

FT. LAUDERDALE, Fla., Oct 23, 2008 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to release third quarter 2008 financial results after market close on Thursday, November 6, 2008. Maurice R. Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and…

FORT LAUDERDALE, Fla., Sep 30, 2008 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) hosted a live surgery during the second annual CIPKA meeting held on September 5 – 6, 2008 at the Mount Carmel New Albany Surgical Hospital Foundation Learning Center in New Albany, Ohio. CIPKA is a continuing medical education program d…

FORT LAUDERDALE, Fla., Aug 28, 2008 (GlobeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferre, M.D., its President and Chief Executive Officer, and Fritz L. LaPorte, its Senior Vice President and Chief Financial Officer, are scheduled to present at the Morgan Stanley Global Healthcare Unplugg…

FORT LAUDERDALE, Fla., Jul 29, 2008 (PrimeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company focused on marketing its Tactile Guidance System^™ (TGS^™), an advanced robotic-arm solution, and its implants for a minimally invasive orthopedic knee procedure, known as MAKOplasty^®, today announced its…

FT. LAUDERDALE, Fla., Jul 15, 2008 (PrimeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to release second quarter 2008 financial results after market close on Tuesday, July 29, 2008. Maurice R. Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chi…

FORT LAUDERDALE, Fla., Apr 29, 2008 (PrimeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company focused on marketing its Tactile Guidance System^™ (TGS^™), an advanced robotic-arm solution, and its implants for minimally invasive orthopedic knee procedures, known as MAKOplasty^®, today announced its f…

FORT LAUDERDALE, Fla., Apr 28, 2008 (PrimeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company focused on marketing its Tactile Guidance System^™ (TGS^™), an advanced robotic-arm solution, and its implants for minimally invasive orthopedic knee procedures, known as MAKOplasty^®, today announced that…

FORT LAUDERDALE, Fla., Apr 23, 2008 (PrimeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferre, M.D., its President and Chief Executive Officer, and Fritz L. LaPorte, its Senior Vice President and Chief Financial Officer, are scheduled to present at the 2008 Morgan Stanley Global Healthcare Un…

FORT LAUDERDALE, Fla., Apr 23, 2008 (PrimeNewswire via COMTEX News Network) — Orthopedic surgeons attending the upcoming Masters Series: Techniques in Arthritis Surgery in Pasadena, California on April 24 – 26, 2008 will have the opportunity to view a live robotic arm partial knee resurfacing procedure aided by a robotic arm. The procedure, called…

FT. LAUDERDALE, Fla., Apr 16, 2008 (PrimeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq: MAKO) announced today that it plans to release first quarter 2008 financial results after market close on Tuesday, April 29, 2008. Maurice R. Ferre, M.D., President and Chief Executive Officer, and Fritz L. LaPorte, Senior Vice President and C…

FT. LAUDERDALE, Fla., Mar 31, 2008 (PrimeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company focused on marketing its Tactile Guidance System^™ (TGS^™), an advanced robotic-arm solution, and its implants for minimally invasive orthopedic knee procedures, known as MAKOplasty^®, today announced its fi…

FT. LAUDERDALE, Fla., Mar 17, 2008 (PrimeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to release fourth quarter and fiscal year 2007 financial results after market close on Monday, March 31, 2008. Maurice R. Ferre, M.D., President and Chief Executive Officer, and Fritz L. LaPorte, Senior Vice…

FT. LAUDERDALE, Fla., Mar 14, 2008 (PrimeNewswire via COMTEX News Network) — MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferre, M.D., President and Chief Executive Officer of MAKO Surgical Corp., is scheduled to present an overview of the company at the 28th Annual Cowen and Company Healthcare Conference in Boston, MA on Tues…

FT. LAUDERDALE, Fla., Feb. 14, 2008 (PRIME NEWSWIRE) — MAKO Surgical Corp. announced today the initial public offering of 5,100,000 shares of its common stock at a price of $10.00 per share, all of which shares are being offered by MAKO Surgical Corp. MAKO Surgical Corp. and a selling stockholder have granted the underwriters a 30-day option to pu…

Ft. Lauderdale, Fla. (September 18, 2007) – MAKO Surgical Corp. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common stock…

FORT LAUDERDALE, Fla. (June 6, 2007) – MAKO Surgical Corp., a developer of minimally invasive, robotic-enabled techniques for knee surgery, announced today that Charles W. Federico has been named to the company’s Board of Directors, effective June 5…

MIAMI, Fla. (April 18, 2007) – MAKO Surgical Corp., a leading American robotics company, has always put a premium on development: development of its technology, development of its market share and development of its people. Today, MAKO announced an initiative to assist in the development of the next generation…

HOLLYWOOD, Fla. (August 8, 2005) – MAKO Surgical Corp., an emerging medical technology company targeting the $4 billion and rapidly growing knee replacement medical device sector, announced today that it has closed on a $20 million Series B round…